Literature DB >> 21941369

The AMPK stress response pathway mediates anoikis resistance through inhibition of mTOR and suppression of protein synthesis.

T L Ng1, G Leprivier, M D Robertson, C Chow, M J Martin, K R Laderoute, E Davicioni, T J Triche, P H B Sorensen.   

Abstract

Suppression of anoikis after detachment of cancer cells from the extracellular matrix is a key step during metastasis. Here we show that, after detachment, mouse embryonic fibroblasts (MEFs) transformed by K-Ras(V12) or ETV6-NTRK3 (EN) activate a transcriptional response overrepresented by genes related to bioenergetic stress and the AMP-activated protein kinase (AMPK) energy-sensing pathway. Accordingly, AMPK is activated in both transformed and non-transformed cells after detachment, and AMPK deficiency restores anoikis to transformed MEFs. However, AMPK activation represses the mTOR complex-1 (mTORC1) pathway only in transformed cells, suggesting a key role for AMPK-mediated mTORC1 inhibition in the suppression of anoikis. Consistent with this, AMPK-/- MEFs transformed by EN or K-Ras show sustained mTORC1 activation after detachment and fail to suppress anoikis. Transformed TSC1-/- MEFs, which are incapable of suppressing mTORC1, also undergo anoikis after detachment, which is reversed by mTORC1 inhibitors. Furthermore, transformed AMPK-/- and TSC1-/- MEFs both have higher total protein synthesis rates than wild-type controls, and translation inhibition using cycloheximide partially restores their anoikis resistance, indicating a mechanism whereby mTORC1 inhibition suppresses anoikis. Finally, breast carcinoma cell lines show similar detachment-induced AMPK/mTORC1 activation and restoration of anoikis by AMPK inhibition. Our data implicate AMPK-mediated mTORC1 inhibition and suppression of protein synthesis as a means for bioenergetic conservation during detachment, thus promoting anoikis resistance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21941369      PMCID: PMC3278733          DOI: 10.1038/cdd.2011.119

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  40 in total

1.  Signaling kinase AMPK activates stress-promoted transcription via histone H2B phosphorylation.

Authors:  David Bungard; Benjamin J Fuerth; Ping-Yao Zeng; Brandon Faubert; Nancy L Maas; Benoit Viollet; David Carling; Craig B Thompson; Russell G Jones; Shelley L Berger
Journal:  Science       Date:  2010-07-15       Impact factor: 47.728

2.  AMP-activated protein kinase induces a p53-dependent metabolic checkpoint.

Authors:  Russell G Jones; David R Plas; Sara Kubek; Monica Buzzai; James Mu; Yang Xu; Morris J Birnbaum; Craig B Thompson
Journal:  Mol Cell       Date:  2005-04-29       Impact factor: 17.970

3.  E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase.

Authors:  Hyung-Gyoo Kang; Jasmine M Jenabi; Jingsong Zhang; Nino Keshelava; Hiroyuki Shimada; William A May; Tony Ng; C Patrick Reynolds; Timothy J Triche; Poul H B Sorensen
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

4.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

5.  Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply.

Authors:  Andrew Y Choo; Sang Gyun Kim; Matthew G Vander Heiden; Sarah J Mahoney; Hieu Vu; Sang-Oh Yoon; Lewis C Cantley; John Blenis
Journal:  Mol Cell       Date:  2010-05-28       Impact factor: 17.970

6.  Hypoxia-inducible factor 1alpha mediates anoikis resistance via suppression of alpha5 integrin.

Authors:  Nadine Rohwer; Martina Welzel; Katjana Daskalow; David Pfander; Bertram Wiedenmann; Katharina Detjen; Thorsten Cramer
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

7.  BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process.

Authors:  Pushkar A Phadke; Kedar S Vaidya; Kevin T Nash; Douglas R Hurst; Danny R Welch
Journal:  Am J Pathol       Date:  2008-02-14       Impact factor: 4.307

8.  Insulin-like growth factor-I-mediated survival from anoikis: role of cell aggregation and focal adhesion kinase.

Authors:  B Valentinis; K Reiss; R Baserga
Journal:  J Cell Physiol       Date:  1998-09       Impact factor: 6.384

9.  Non-oncogene addiction and the stress phenotype of cancer cells.

Authors:  Nicole L Solimini; Ji Luo; Stephen J Elledge
Journal:  Cell       Date:  2007-09-21       Impact factor: 41.582

10.  Inhibition of 4E-BP1 sensitizes U87 glioblastoma xenograft tumors to irradiation by decreasing hypoxia tolerance.

Authors:  Ludwig Dubois; Michaël G Magagnin; Arjen H G Cleven; Sherry A Weppler; Beat Grenacher; Willy Landuyt; Natasja Lieuwes; Philippe Lambin; Thomas A Gorr; Marianne Koritzinsky; Bradly G Wouters
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-15       Impact factor: 7.038

View more
  52 in total

1.  Nuclear respiratory factor 1 promotes spheroid survival and mesenchymal transition in mammary epithelial cells.

Authors:  Yuanshuai Zhou; Zhongjuan Xu; Daniel Quan; Fan Zhang; Hai Zhang; Tongqian Xiao; Shulan Hou; Hong Qiao; Olivier Harismendy; Jean Y J Wang; Guangli Suo
Journal:  Oncogene       Date:  2018-07-11       Impact factor: 9.867

2.  Mechanical stretch activates mammalian target of rapamycin and AMP-activated protein kinase pathways in skeletal muscle cells.

Authors:  Naoya Nakai; Fuminori Kawano; Ken Nakata
Journal:  Mol Cell Biochem       Date:  2015-05-14       Impact factor: 3.396

Review 3.  Metabolic reprogramming in the tumour microenvironment: a hallmark shared by cancer cells and T lymphocytes.

Authors:  Katrina E Allison; Brenda L Coomber; Byram W Bridle
Journal:  Immunology       Date:  2017-07-10       Impact factor: 7.397

Review 4.  Starvation and Pseudo-Starvation as Drivers of Cancer Metastasis through Translation Reprogramming.

Authors:  Custodia García-Jiménez; Colin R Goding
Journal:  Cell Metab       Date:  2018-12-20       Impact factor: 27.287

Review 5.  Targeting the LKB1 tumor suppressor.

Authors:  Rui-Xun Zhao; Zhi-Xiang Xu
Journal:  Curr Drug Targets       Date:  2014-01       Impact factor: 3.465

Review 6.  Emerging roles of aerobic glycolysis in breast cancer.

Authors:  Z Wu; J Wu; Q Zhao; S Fu; J Jin
Journal:  Clin Transl Oncol       Date:  2019-07-29       Impact factor: 3.405

7.  Regulation of autophagy during ECM detachment is linked to a selective inhibition of mTORC1 by PERK.

Authors:  A Avivar-Valderas; E Bobrovnikova-Marjon; J Alan Diehl; N Bardeesy; J Debnath; J A Aguirre-Ghiso
Journal:  Oncogene       Date:  2012-11-19       Impact factor: 9.867

8.  AMPK Promotes Aberrant PGC1β Expression To Support Human Colon Tumor Cell Survival.

Authors:  Kurt W Fisher; Binita Das; Hyun Seok Kim; Beth K Clymer; Drew Gehring; Deandra R Smith; Diane L Costanzo-Garvey; Mario R Fernandez; Michael G Brattain; David L Kelly; John MacMillan; Michael A White; Robert E Lewis
Journal:  Mol Cell Biol       Date:  2015-09-08       Impact factor: 4.272

9.  Mutation of the salt bridge-forming residues in the ETV6-SAM domain interface blocks ETV6-NTRK3-induced cellular transformation.

Authors:  Naniye Cetinbas; Helen Huang-Hobbs; Cristina Tognon; Gabriel Leprivier; Jianghong An; Steven McKinney; Mary Bowden; Connie Chow; Martin Gleave; Lawrence P McIntosh; Poul H Sorensen
Journal:  J Biol Chem       Date:  2013-06-24       Impact factor: 5.157

10.  The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation.

Authors:  Gabriel Leprivier; Marc Remke; Barak Rotblat; Adrian Dubuc; Abigail-Rachele F Mateo; Marcel Kool; Sameer Agnihotri; Amal El-Naggar; Bin Yu; Syam Prakash Somasekharan; Brandon Faubert; Gaëlle Bridon; Cristina E Tognon; Joan Mathers; Ryan Thomas; Amy Li; Adi Barokas; Brian Kwok; Mary Bowden; Stephanie Smith; Xiaochong Wu; Andrey Korshunov; Thomas Hielscher; Paul A Northcott; Jason D Galpin; Christopher A Ahern; Ye Wang; Martin G McCabe; V Peter Collins; Russell G Jones; Michael Pollak; Olivier Delattre; Martin E Gleave; Eric Jan; Stefan M Pfister; Christopher G Proud; W Brent Derry; Michael D Taylor; Poul H Sorensen
Journal:  Cell       Date:  2013-05-23       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.